Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

Completed · Not applicable · Has a placebo group

Conditions studied: Non-melanomatous Skin Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of acitretin may be an effective way to prevent the recurrence or further development of skin cancer. PURPOSE: Randomized clinical trial to study the effectiveness of acitretin in preventing skin cancers in patients with at least two previously treated skin cancers who have undergone organ transplantation.

Key facts

Study ID

NCT00003611

Run by

Alliance for Clinical Trials in Oncology

People needed

129

Starts

2000-05-01

Expected to finish

2003-06-01

Last updated by the study team

2016-07-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• CCOP - Scottsdale Oncology Program — Scottsdale, Arizona, United States
• Mayo Clinic — Jacksonville, Florida, United States
• CCOP - Illinois Oncology Research Association — Peoria, Illinois, United States
• CCOP - Carle Cancer Center — Urbana, Illinois, United States
• CCOP - Iowa Oncology Research Association — Des Moines, Iowa, United States
• CCOP - Wichita — Wichita, Kansas, United States
• Mayo Clinic Cancer Center — Rochester, Minnesota, United States
• CentraCare Health Plaza — Saint Cloud, Minnesota, United States
• Medcenter One Health System — Bismarck, North Dakota, United States
• Rapid City Regional Hospital — Rapid City, South Dakota, United States
• CCOP - Sioux Community Cancer Consortium — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.